Trends in upper respiratory tract infections and antibiotic
prescriptions during the COVID-19 pandemic -- a national observational
study
Abstract
Objectives: The purpose of this study was to compare the incidences of
common upper airway infections and their complications, and of
antibiotic prescription rates during 2020, when the COVID-19 pandemic
struck, and the previous year. Study design: Retrospective national
register study Setting/source population: The Swedish population in 2019
and 2020. Methods: The Swedish Board of Health and Welfare statistics
data base, which includes all out- and inpatient diagnoses in
specialised care was used to retrieve the number of otitis media,
rhinosinusitis, pharyngotonsillitis, acute mastoiditis and peritonsillar
abscess diagnoses in various age groups during 2019 and 2020. The number
of prescriptions of oral antibiotics used to treat upper airway
infections was collected from the Swedish E-Health Authority, which
covers all prescriptions in Sweden. Population data were retrieved from
Statistics Sweden. Results: There was strong evidence of a substantial
decrease (approximately 40%) in otitis media, rhinosinusitis and
pharyngotonsillitis cases in the population as a whole in 2020 compared
to 2019. For otitis media, the decrease was most pronounced among
children, whereas rhinosinusitis and pharyngotonsillitis incidence
decreased to a similar extent in adults, as well. Furthermore, there was
equally strong evidence that acute mastoiditis decreased by 40% in
children and adolescents and that peritonsillitis in adults decreased by
24%. The decrease in infections was accompanied by a corresponding
decrease in antibiotic prescriptions. Conclusion: The social distancing
measures introduced during 2020 were followed by a significant decrease
in upper airway infections and antibiotic prescriptions.